| ISIN | LU0719899097 |
|---|---|
| Valor Number | 14685997 |
| Bloomberg Global ID | |
| Fund Name | Exane Equity Select Europe Fund B |
| Fund Provider |
Exane Asset Management
75008 Paris |
| Fund Provider | Exane Asset Management |
| Representative in Switzerland |
BNP Paribas, Paris, Zurich Branch Zürich |
| Distributor(s) | CREDIT SUISSE AG |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The Sub-Fund’s investment objective is to outperform its Benchmark Index over the recommended investment horizon. The Sub-Fund is intended for all categories of investors seeking an active investment approach to the European equity markets. |
| Peculiarities |
| Current Price * | 286.95 EUR | 01.12.2025 |
|---|---|---|
| Previous Price * | 287.17 EUR | 28.11.2025 |
| 52 Week High * | 290.71 EUR | 12.11.2025 |
| 52 Week Low * | 229.61 EUR | 09.04.2025 |
| NAV * | 286.95 EUR | 01.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 879,205,611 | |
| Unit/Share Assets *** | 53,960,009 | |
| Trading Information SIX | ||
| YTD Performance | +15.84% |
31.12.2024 - 01.12.2025
31.12.2024 01.12.2025 |
|---|---|---|
| YTD Performance (in CHF) | +15.07% |
31.12.2024 - 01.12.2025
31.12.2024 01.12.2025 |
| 1 month | +1.32% |
03.11.2025 - 01.12.2025
03.11.2025 01.12.2025 |
| 3 months | +6.07% |
01.09.2025 - 01.12.2025
01.09.2025 01.12.2025 |
| 6 months | +5.32% |
02.06.2025 - 01.12.2025
02.06.2025 01.12.2025 |
| 1 year | +14.64% |
02.12.2024 - 01.12.2025
02.12.2024 01.12.2025 |
| 2 years | +29.74% |
01.12.2023 - 01.12.2025
01.12.2023 01.12.2025 |
| 3 years | +37.96% |
01.12.2022 - 01.12.2025
01.12.2022 01.12.2025 |
| 5 years | +54.56% |
01.12.2020 - 01.12.2025
01.12.2020 01.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ASML Holding NV | 4.39% | |
|---|---|---|
| Stoxx Europe 600 Health Care Price Eur | 3.47% | |
| Siemens AG | 3.47% | |
| Enel SpA | 3.41% | |
| SAP SE | 3.20% | |
| AstraZeneca PLC | 2.94% | |
| Reckitt Benckiser Group PLC | 2.89% | |
| STOXX Europe 600 Telecom PR EUR | 2.44% | |
| Shell PLC | 2.40% | |
| Nordea Bank Abp | 2.27% | |
| Last data update | 30.09.2025 | |
| TER | |
|---|---|
| TER date | |
| Performance Fee *** | 15.00% |
| PTR | |
| Max. Management Fee *** | 1.80% |
| Ongoing Charges *** | 1.94% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |